EquiReason

EquiReason research coverage

Ingersoll Rand Inc. IR

Industrials · Specialty Industrial Machinery

24quarters analysed
12SEC filings read
2segments identified
10institutional managers tracked

Segments it reports

The business segments Ingersoll Rand Inc. reports in its own SEC filings.

  • Industrial Technologies And Services Segment
  • Precision And Science Technologies Segment

Product lines it reports

The product and service lines Ingersoll Rand Inc. breaks its revenue into.

  • Original Equipment
  • Aftermarket

Where its revenue is reported

The geographies Ingersoll Rand Inc. reports revenue for. How much comes from each is in the product.

  • United States
  • EMEA
  • China
  • Other Americas
  • Other Asia Pacific

What we read

The sources behind this company, and how many records of each we hold.

  • Financial statements25
  • Quarterly metric series12
  • Business segments2
  • SEC filings12
  • Insider transactions (Form 4)6
  • Institutional positions (13F)7
  • Earnings events2
  • Earnings quality checks6
  • Estimate revisions11
  • GAAP vs non-GAAP reconciliation1
  • Seasonal pattern6
  • Multi-period trajectory7
  • Inflection detection1
  • Fiscal calendar1
  • Index membership4

What we look for

Every company is run through the same checks. Both answers are reported — a signal we looked for and did not find is as much a fact as one we did.

  • Revenue series24
  • Margin series1
  • Cash flow series24
  • Earnings series24
  • Operating cash flow series24
  • Guidance changesnot found
  • Per-share seriesnot found

This page says how much of Ingersoll Rand Inc. we have read. What any of it means — the direction, the dates, the evidence and what would overturn it — is inside the product.

Open IR in EquiReason

This page publishes coverage counts and reported breakdown names, but no financial figures, price data, rankings or investment conclusions. Sources are SEC filings, earnings calls and public institutional disclosures. How the research is made · All companies

Ingersoll Rand Inc. (IR) — research coverage | EquiReason